The Effects of Suvorexant on Sleep, Stress, and Cue-reactivity in Methamphetamine Use Disorder

NCT05711862 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Lack of enrollment

Conditions

Methamphetamine Use Disorder

Interventions

DRUG: suvorexant (SUVO)
DRUG: Placebo

Sponsor

The University of Texas Health Science Center, Houston